ArticlePloS one2026
Explainable depth-wise and channel-wise fusion models for multi-class skin lesion classification.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep Learning for Brain Tumour Analysis: A Systematic Review of CNN-Transformer Hybrids in Multimodal Imaging.International journal of biomedical imaging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The clinical adoption of deep learning in dermatology requires models that are not only highly accurate but also transparent and trustworthy. To address this dual challenge, this study presents a systematic investigation into deep feature fusion, exploring how to effectively combine complementary representations from diverse neural network architectures. We design and rigorously evaluate six distinct fusion models, first investigating depth-wise and channel-wise strategies for integrating features from powerful Convolutional Neural Network (CNN) backbones, and subsequently incorporating the global contextual awareness of Vision Transformers (ViTs). Evaluated on the challenging 7-class HAM10000 dataset, our optimized architecture achieves a weighted average Precision, Recall, and F1 score of 90%, demonstrating superior diagnostic performance. Crucially, our comprehensive explainable AI (XAI) analysis using Grad-CAM and SHAP reveals that the fusion strategy directly dictates the model's clinical interpretability; our most effective models learn to base their predictions on salient dermatological features, such as border irregularity and color variegation, in a manner that aligns with expert reasoning. This work provides a robust framework and valuable architectural insights for developing the next generation of high-performing, clinically reliable, and transparent AI-powered diagnostic tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.